Blythe G. Thomson, MD, is clinical associate professor at Seattle Children’s Hospital. She earned her MD magna cum laude from Ohio State University College of Medicine. Locally at Seattle Children’s Hospital, she serves on the Institutional Review Board, the Human Subjects Protection Advisory Committee, the Department of Pediatrics Recognition Committee, Ambulatory Oversight Committee and Institutional Biosafety Committee of the Seattle Cancer Care Alliance.
She is a member of the Children’s Oncology Group Steering Committee for Relapsed Leukemia. Additionally, she is the Medical Director of the Pediatric Clinical Research Center at Seattle Children’s, part of the University of Washington ITHS. Her clinical and research interests include leukemia research. She is taking a leading local role on several research projects for the treatment of leukemia, including the INTERFANT study for infant ALL and research studies for newly diagnosed pre-B-cell leukemia. She is participating member of the Therapeutic Advances in Childhood Leukemia consortium to investigate novel therapies for relapsed and refractory leukemia. Additionally, Thomson is the local investigator for industry-sponsored trials for relapsed leukemia.